A small dose of hydrogen peroxide enhances tumor necrosis factor-alpha toxicity in inducing human vascular endothelial cell apoptosis: Reversal with propofol

Anesthesia and Analgesia

Volumn 103, Issue 1, 2006, Pages 110-116

  Luo, Tao ^a   Xia, Zhengyuan ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROPOFOL; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 33745815354     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000221183.02244.80     Document Type: Article

References (28)

1. Verrier ED, Boyle EM Jr. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;62:915-22.
2. Scarabelli T, Stephanou A, Rayment N, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001;104:253-6.
3. Murphy PG, Myers DS, Davies MJ, et al. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992;68:613-8.
4. Kokita N, Hara A. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 1996;84:117-27.
5. Luo T, Xia Z, Ansley DM, et al. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg 2005;100:1653-9.
6. Curello S, Ceconi C, de Giuli F, et al. Oxidative stress during reperfusion of human hearts: potential sources of oxygen free radicals. Cardiovasc Res 1995;29:118-25.
7. Chandrasekar B, Smith JB, Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-kappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001;103:2296-302.
8. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
9. Xia Z, Gu J, Ansley DM, et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 2003;126:1404-10.
10. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol 1990;186:209-20.
11. Woo CH, Eom YW, Yoo MH, et al. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 2000;275:32357-62.
12. Lo YY, Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 1995;270:11727-30.
13. Marsh SA, Laursen PB, Pat BK, et al. Bcl-2 in endothelial cells is increased by vitamin E and alpha-lipoic acid supplementation but not exercise training. J Mol Cell Cardiol 2005;38:445-51.
14. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-20.
15. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101: 299-310.
16. Bein B, Renner J, Caliebe D, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005;100:610-6.
17. Corcoran TB, Englel A, Sakamoto H, et al. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2004;18:592-604.
18. Xia Z, Godin DV, Chang TK, et al. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F(2t)-isoprostane formation. Can J Physiol Pharmacol 2003;81:14-21.
19. Xia Z, Godin DV, Ansley DM. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 2003;59:113-21.
20. Xia Z, Godin DV, Ansley DM. Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Can J Physiol Pharmacol 2004;82:919-26.
21. Peng Z, Luo M, Ye S, et al. Antioxidative and anti-endotoxin effects of propofol on endothelial cells. Chin Med J (Engl) 2003;116:731-5.
22. Ansley DM, Sun J, Visser WA, et al. High dose propofol enhances red cell antioxidant capacity during cardiopulmonary bypass in humans. Can J Anaesth 1999;46:641-8.
23. Burlacu A, Jinga V, Gafencu AV, et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res 2001;306:409-16.
24. Badrichani AZ, Stroka DM, Bilbao G, et al. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NFkappaB. J Clin Invest 1999;103:543-53.
25. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
26. Englelhard K, Werner C, Eberspacher E, et al. Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur J Anaesthesiol 2004;21:530-7.
27. Englelhard K, Werner C, Eberspacher E, et al. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 2004;101:912-7.
28. Sayin MM, Ozatamer O, Tasoz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002;89:242-6.